Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorhexidine gluconate + benzydamine hydrochloride is a combination medication used to treat oral and throat conditions. Chlorhexidine gluconate is a broad-spectrum antiseptic that binds to oral surfaces, providing immediate bactericidal effects followed by prolonged bacteriostatic action against various microorganisms. Benzydamine hydrochloride is a non-steroidal anti-inflammatory drug with local anesthetic properties that selectively binds to inflamed tissue and blocks inflammatory chemical messengers. This combination effectively treats conditions like gingivitis, pharyngitis, mouth ulcers, and provides pain relief for oral inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine gluconate + benzydamine hydrochloride.